FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003604987> ?p ?o ?g. }

• W3003604987 endingPage "e1920177" @default.
• W3003604987 startingPage "e1920177" @default.
• W3003604987 abstract "There are high rates of maternal and newborn morbidity and mortality associated with opioid use disorder (OUD). Integrating OUD treatment in obstetric practices for pregnant and postpartum women via telemedicine can increase access to care and reduce the consequences of OUD. Evaluation of this care delivery model, however, is needed before widespread adoption.To compare maternal and newborn outcomes among pregnant women with OUD receiving care via telemedicine vs in person.A nonrandomized controlled trial including 98 women receiving perinatal OUD treatment in 4 outpatient obstetric practices by telemedicine or in person and followed up until 6 to 8 weeks post partum was conducted from September 4, 2017, to December 31, 2018. Logistic regression with propensity score adjustment was applied to reduce group selection bias and control for potentially confounding variables.Participants were seen weekly for 4 weeks, every 2 weeks for 4 weeks, and monthly thereafter and provided relapse prevention therapy and buprenorphine.The outcomes were retention in treatment, defined as uninterrupted addiction treatment during pregnancy through 6 to 8 weeks post partum; urine drug screen results at delivery and 6 to 8 weeks post partum; and a neonatal abstinence syndrome (NAS) diagnosis collected via electronic health records.The mean (SD) age of the 98 pregnant women was 30.23 (5.12) years. Of these, 41 of 44 women (93.2%) in the telemedicine group and 48 of 54 women (88.9%) in the in-person group chose to continue treatment in the program after an initial evaluation. After propensity score weighting and doubly robust estimation, no significant differences were found between groups in retention in treatment at 6 to 8 weeks post partum (telemedicine: 80.4% vs in person: 92.7%; treatment effect, -12.2%; 95% CI, -32.3% to -4.4%). Similarly, after propensity score weighting and doubly robust estimation, there were no significant group differences in rates of NAS (telemedicine: 45.4% vs in person: 63.2%; treatment effect, -17.8%; 95% CI, -41.0% to 8.9%).In this nonrandomized controlled trial, virtually integrated OUD care in obstetric practices produced similar maternal and newborn outcomes compared with in-person care. These findings may have important public health implications for combatting the opioid crisis and its consequences on pregnant women and their families. Future large randomized clinical trials are needed.ClinicalTrials.gov identifier: NCT04049032." @default.
• W3003604987 created "2020-02-07" @default.
• W3003604987 creator A5001554161 @default.
• W3003604987 creator A5008289850 @default.
• W3003604987 creator A5014787924 @default.
• W3003604987 creator A5015831269 @default.
• W3003604987 creator A5016018592 @default.
• W3003604987 creator A5036627459 @default.
• W3003604987 creator A5052833626 @default.
• W3003604987 creator A5066622934 @default.
• W3003604987 date "2020-01-31" @default.
• W3003604987 modified "2023-10-01" @default.
• W3003604987 title "Treatment of Opioid Use Disorder in Pregnant Women via Telemedicine" @default.
• W3003604987 cites W1987623215 @default.
• W3003604987 cites W1989415915 @default.
• W3003604987 cites W2009000630 @default.
• W3003604987 cites W2014888717 @default.
• W3003604987 cites W2025376268 @default.
• W3003604987 cites W2025988777 @default.
• W3003604987 cites W2033891285 @default.
• W3003604987 cites W2048565444 @default.
• W3003604987 cites W2050618420 @default.
• W3003604987 cites W2052920403 @default.
• W3003604987 cites W2056108924 @default.
• W3003604987 cites W2057319741 @default.
• W3003604987 cites W2091750888 @default.
• W3003604987 cites W2110818436 @default.
• W3003604987 cites W2136341109 @default.
• W3003604987 cites W2143290412 @default.
• W3003604987 cites W2150291618 @default.
• W3003604987 cites W2151408266 @default.
• W3003604987 cites W2156414575 @default.
• W3003604987 cites W2164822993 @default.
• W3003604987 cites W2401517507 @default.
• W3003604987 cites W2469955170 @default.
• W3003604987 cites W2575251737 @default.
• W3003604987 cites W2788424177 @default.
• W3003604987 cites W2791800224 @default.
• W3003604987 cites W2801367882 @default.
• W3003604987 cites W2886735328 @default.
• W3003604987 cites W2894369234 @default.
• W3003604987 cites W2907713966 @default.
• W3003604987 cites W2909725163 @default.
• W3003604987 cites W2914263188 @default.
• W3003604987 cites W2922761638 @default.
• W3003604987 cites W4233124781 @default.
• W3003604987 cites W4235088927 @default.
• W3003604987 cites W4240483535 @default.
• W3003604987 cites W4250162278 @default.
• W3003604987 doi "https://doi.org/10.1001/jamanetworkopen.2019.20177" @default.
• W3003604987 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7042863" @default.
• W3003604987 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32003816" @default.
• W3003604987 hasPublicationYear "2020" @default.
• W3003604987 type Work @default.
• W3003604987 sameAs 3003604987 @default.
• W3003604987 citedByCount "30" @default.
• W3003604987 countsByYear W30036049872020 @default.
• W3003604987 countsByYear W30036049872021 @default.
• W3003604987 countsByYear W30036049872022 @default.
• W3003604987 countsByYear W30036049872023 @default.
• W3003604987 crossrefType "journal-article" @default.
• W3003604987 hasAuthorship W3003604987A5001554161 @default.
• W3003604987 hasAuthorship W3003604987A5008289850 @default.
• W3003604987 hasAuthorship W3003604987A5014787924 @default.
• W3003604987 hasAuthorship W3003604987A5015831269 @default.
• W3003604987 hasAuthorship W3003604987A5016018592 @default.
• W3003604987 hasAuthorship W3003604987A5036627459 @default.
• W3003604987 hasAuthorship W3003604987A5052833626 @default.
• W3003604987 hasAuthorship W3003604987A5066622934 @default.
• W3003604987 hasBestOaLocation W30036049871 @default.
• W3003604987 hasConcept C118552586 @default.
• W3003604987 hasConcept C126322002 @default.
• W3003604987 hasConcept C131872663 @default.
• W3003604987 hasConcept C151956035 @default.
• W3003604987 hasConcept C160735492 @default.
• W3003604987 hasConcept C162324750 @default.
• W3003604987 hasConcept C170493617 @default.
• W3003604987 hasConcept C17923572 @default.
• W3003604987 hasConcept C194828623 @default.
• W3003604987 hasConcept C2778767360 @default.
• W3003604987 hasConcept C2778949969 @default.
• W3003604987 hasConcept C2779234561 @default.
• W3003604987 hasConcept C2779418921 @default.
• W3003604987 hasConcept C2779891985 @default.
• W3003604987 hasConcept C2780687700 @default.
• W3003604987 hasConcept C2781063702 @default.
• W3003604987 hasConcept C50522688 @default.
• W3003604987 hasConcept C54355233 @default.
• W3003604987 hasConcept C71924100 @default.
• W3003604987 hasConcept C86803240 @default.
• W3003604987 hasConceptScore W3003604987C118552586 @default.
• W3003604987 hasConceptScore W3003604987C126322002 @default.
• W3003604987 hasConceptScore W3003604987C131872663 @default.
• W3003604987 hasConceptScore W3003604987C151956035 @default.
• W3003604987 hasConceptScore W3003604987C160735492 @default.
• W3003604987 hasConceptScore W3003604987C162324750 @default.
• W3003604987 hasConceptScore W3003604987C170493617 @default.
• W3003604987 hasConceptScore W3003604987C17923572 @default.

• next